Research Technologies
Roche is at the forefront when it comes to collaboration with biotechs at all development stages to drive the application of technology and modality platforms that have the potential to transform discovery as well as generate innovative medicines beyond the standard of care.
Partnering opportunities we are looking for:
- Novel modalities and enabling technologies to expand the druggable target space
- Targeted or intracellular delivery
- Artificial intelligence for drug discovery
- Genomic Medicine platforms
Example partnerships
Skyhawk – research collaboration to discover and develop small molecule RNA splicing modifiers for oncology and neurodegenerative diseases
Heptares – research collaboration to discover and develop novel medicines that modulate G-protein-coupled receptor targets across a range of diseases
Arrakis Therapeutics - research collaboration to discover and develop RNA-targeted small molecules against a broad set of targets across Roche's R&D areas
Vividion Therapeutics - research collaboration to discover and develop compounds targeting novel E3 ligases and a range of oncology and immunology therapeutic targets based on Vividion's covalent chemistry
Bicycle Therapeutics - research collaboration to discover and develop immunomodulatory bicyclic peptides for the treatment of cancer
